Stay updated on Safety of Tarlatamab in Adults With SCLC Clinical Trial
Sign up to get notified when there's something new on the Safety of Tarlatamab in Adults With SCLC Clinical Trial page.

Latest updates to the Safety of Tarlatamab in Adults With SCLC Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe footer revision label updated from v3.6.3 to v3.6.4. This reflects a new build of the ClinicalTrials.gov interface.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check33 days agoChange DetectedThe footer revision updated from v3.6.2 to v3.6.3. This represents a minor site/template update and does not alter page content.SummaryDifference0.0%

- Check40 days agoChange DetectedA new release entry, Revision: v3.6.2, has been added to the study record history and the older Revision: v3.6.0 entry has been removed. This updates the documented software version reflected on the page.SummaryDifference0.0%

- Check54 days agoChange DetectedRecruitment status updated to no longer look for participants, indicating enrollment has closed. The history also shows a new revision (v3.6.0) to the record, following the previous v3.5.5.SummaryDifference0.2%

- Check61 days agoChange DetectedA new revision entry, v3.5.5, was added to the history, replacing the prior v3.5.4.SummaryDifference0.0%

- Check82 days agoChange DetectedThe page footer revision label changed from v3.5.3 to v3.5.4, indicating a minor version update to the page.SummaryDifference0.0%

Stay in the know with updates to Safety of Tarlatamab in Adults With SCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Tarlatamab in Adults With SCLC Clinical Trial page.